I think $10 is save bet mate, I doubt you will get that wrong, lol
FWIW, Neu have forecast the revenue 2023 it’s in their presentation, the EPS is based on this forcast from them not me, Simply Wall Street have picked up the same re EPS and growth, the P/E is up to the market based on growth etc, you can choose your own, x16 as I pointed out is S&P 500 average however my understanding is Developing BIO tend to attract higher P/E ratios.
We got to $9 with no FDA approval, so no commercial asset and no ROW deal licensing which is 1/2 of our future commercial revenue.
Anyway market decides in the end my tip is most will use tools like EPS and P/E ratio to see upside here as these tools havent been invented today!
I think $10 is save bet mate, I doubt you will get that wrong,...
-
- There are more pages in this discussion • 90 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.17 |
Change
0.070(0.35%) |
Mkt cap ! $2.578B | |||
| Open | High | Low | Value | Volume |
| $20.39 | $20.53 | $20.14 | $4.102M | 202.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 249 | $20.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.31 | 790 | 1 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |